aprepitant 125mg capsules
martindale pharmaceuticals ltd - aprepitant - oral capsule - 125mg
aprepitant mylan 125 mg/80 mg hard capsules
ej busuttil ltd busuttil buildings, triq l-ghadam, central business district zone 1, birkirkara, cbd 1060, malta - hard capsule - aprepitant 125 mg aprepitant 80 mg - antiemetics and antinauseants
fosaprepitant-dimeglumin tillomed 150 mg pulver zur herstellung einer infusionslösung
emend
merck sharp & dohme (new zealand) limited - aprepitant 125mg - capsule - 125 mg - active: aprepitant 125mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.
emend
merck sharp & dohme (new zealand) limited - aprepitant 40mg - capsule - 40 mg - active: aprepitant 40mg excipient: hyprolose micronised sodium lauryl sulphate opaque white and mustard yellow hard gelatin capsule (contains titanium dioxide, yellow iron) microcrystalline cellulose purified water sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.
emend
merck sharp & dohme (new zealand) limited - aprepitant 80mg - capsule - 80 mg - active: aprepitant 80mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.
emend tri-pack
merck sharp & dohme (new zealand) limited - aprepitant 80mg; aprepitant 125mg - combination capsule - 80/125mg - active: aprepitant 80mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose active: aprepitant 125mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.
ivemend 150mg powder for solution for infusion vials
merck sharp & dohme ltd - fosaprepitant dimeglumine - powder for solution for infusion - 150mg
aprepitant stada 80 mg hartkapseln
aprepitant stada 125 mg hartkapseln